Cargando…
Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis
The development of multitargeting drugs is an emerging trend in cancer research. To promote further development and clinical application of multitargeting drugs, this research was performed. MTT assay and flow cytometry of Annexin V/propidium iodide staining were used to confirm the proapoptotic eff...
Autores principales: | Zheng, Haofeng, Liang, Guancan, Chen, Yanxiong, Lin, Sijie, Liu, Wei, Fang, Youqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661095/ https://www.ncbi.nlm.nih.gov/pubmed/29164150 http://dx.doi.org/10.1155/2017/8050313 |
Ejemplares similares
-
Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison
por: Zheng, Haofeng, et al.
Publicado: (2017) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis
por: Ikeda, Daiki, et al.
Publicado: (2013) -
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
por: Swiatly, Agata, et al.
Publicado: (2018) -
iTRAQ-based proteomic analysis of endotoxin tolerance induced by lipopolysaccharide
por: Zhang, Qian, et al.
Publicado: (2019)